Drug Development

Ipsen is a global biotechnology specialty care company. Its strategy is based on fast growing specialty care drugs in oncology, endocrinology, neurology and hematology, and primary care drugs, significantly contributing to research financing.

We're working in pain management, urology, endocrinology and oncology. We're evaluating new drug delivery technologies to create innovative new medicines. We're empowering our commercial team to work with physicians and payers to become real partners in medical care, not just suppliers

ImmunoGen, Inc. develops targeted anticancer therapeutics using our expertise in cancer biology, engineered antibodies and highly potent cancer-cell killing agents.

Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases. The company developed Tyzeka/Sebivo through a co development agreement with Novartis Pharma AG for the treatment of patients with chronic hepatitis B in the United States and European Union for the treatment of patients with chronic hepatitis B.

Hamilton Storage Technologies, Inc. has a commitment to improve Life Science process management. We envisioned dramatically improving customer efficiency by automating manual processes and integrating isolated upstream and downstream applications that plagued sample management in drug discovery.

Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune disease, and diagnostic testing.

GSK employees serve US communities by discovering, developing, and delivering new medicines, vaccines, and other healthcare products to help people do more, feel better, and live longer

EPIX Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics through the use of its proprietary silico drug discovery platform.

ESA enables answers to pressing applications challenges by
applying its expertise in specialty detection and electrochemistry, combined with components, kits, and reagents, for analytical laboratories, commercial diagnostics laboratories, and the clinical point-of-care setting.

EMD Serono, Inc. is a leader in the biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve patients' lives. Focusing on specialized areas including neurodegenerative diseases, fertility, metabolic endocrinology, as well as oncology as an emerging area of expertise, EMD Serono is committed to discovering and developing innovative products that meet unmet medical needs.